Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer

Published:2009-01 Issue:1 Volume:32 Page:12-21
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Moo-Young Tricia A.,Larson Justin W.,Belt Brian A.,Tan Marcus C.,Hawkins William G.,Eberlein Timothy J.,Goedegebuure Peter S.,Linehan David C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. Immunity to tumour antigens;Li;Curr Pharm Des,2005

2. Innovative treatments for pancreatic cancer;Lieberman;Surg Clin North Am,2001

3. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients;Bellone;Am J Pathol,1999

4. Systemic and local immunosuppression in pancreatic cancer patients;von Bernstorff;Clin Cancer Res,2001

5. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan);Lin;Cancer Causes Control,2006

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

2. LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma;Cell Death & Differentiation;2024-08-14

3. Dihydroartemisinin breaks the immunosuppressive tumor niche during cisplatin treatment in Hepatocellular carcinoma;Acta Histochemica;2024-05

4. Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination;Discover Oncology;2023-12-01

5. Modulating Treg stability to improve cancer immunotherapy;Trends in Cancer;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3